Author

Krista Patlovich

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

A culture change initiative to reduce end-of-life systemic anticancer therapy and intensive healthcare utilization.

607 Background: Receipt of systemic anticancer therapy (SACT) near the end of life (EOL) is associated with potentially low-value care, including increased emergency department visits, hospitalizations, and intensive care unit (ICU) utilization and lower hospice utilization. At UT MD Anderson, a large freestand...

R. Ratan, J. Xiang, Lee Cheng et al. · JCO Oncology Practice · 0 citations

Open access Oct 2026

Transitioning from reactive to pretreatment DPYD testing through a system-wide screening program at a comprehensive cancer center.

544 Background: Fluoropyrimidines (FP), including 5-fluorouracil and capecitabine, are among the most commonly used systemic anticancer therapies. Deficiency of the dihydropyrimidine dehydrogenase (DPD) enzyme, encoded by the DPYD gene, is associated with an increased risk of severe, potentially life-threaten...

V. Higbie, Wendy M. Covert, Sarah Fayle et al. · JCO Oncology Practice · 0 citations